Clinical Trials Logo

Clinical Trial Summary

Antibiotic resistance is a major threat in modern medicine. Overuse of antibiotics is an important driver of antibiotic resistance. However, some authors have shown that up to 50% of antibiotic treatments in critically ill patients are inappropriate, mostly because they are used in patients with non-bacterial infections. In order to improve antibiotic use, several antibiotic stewardship programs have been implemented worldwide. However, only few of them have taken into account the determinants of prescribing behaviors. Yet, these determinants have been shown to play a role among general practitioners of hospital doctors. Nevertheless, none of these factors have been studied among intensivists. The current project represent phase 1 of the study : construction and validation of a questionnaire.


Clinical Trial Description

Antibiotic resistance is a major threat in modern medicine. Overuse of antibiotics is an important driver of antibiotic resistance. In critical care setting, antibiotic therapies are widely used due to the high number of patients presenting with sepsis. However, some authors have shown that up to 50% of antibiotic treatments in critically ill patients are inappropriate, mostly because they are used in patients with non-bacterial infections. In order to improve antibiotic use, several antibiotic stewardship programs have been implemented worldwide. However, only few of them have taken into account the determinants of prescribing behaviors. Yet, these determinants have been shown to play a role among general practitioners of hospital doctors. Nevertheless, none of these factors have been studied among intensivists. The study is designed to investigate social, cultural, contextual and personal factors influencing antibiotic prescribing among French intensivists. The design will consist of three phases: - Phase 1: construction and validation of a questionnaire - Phase 2: the questionnaire will be sent to all intensivist, including residents, in France - Phase 3: qualitative study, based on semi-structured interviews. The current project represent phase 1 of the study. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04820062
Study type Observational
Source Centre Hospitalier Universitaire de Saint Etienne
Contact GUILLAUME THIERY, MD PHD
Phone (0)4 77 12 78 53
Email guillaume.thiery@chu-st-etienne.fr
Status Not yet recruiting
Phase
Start date August 2021
Completion date September 1, 2022

See also
  Status Clinical Trial Phase
Recruiting NCT04961580 - PK/PD of Ceftazidime Avitbatan Sodium in Children With Severe Infection
Completed NCT04187755 - Cefepime vs Ceftazidime as Empirical Therapy for Neutropenic Fever Phase 4
Active, not recruiting NCT05027893 - Complications After Lower Third Molar Surgery N/A
Completed NCT05260554 - Effect of Cranberry Extract on the Urinary System
Completed NCT03848104 - Evaluation of the Use of Cefoxitin in Combination in Continuous Parenteral Administration in the Treatment of Bone and Joint Infections
Completed NCT04196387 - Antimicrobial Resistance Rate In Escherichia Coli And Klebsiella Pneumonia : A Retrospective Study
Completed NCT04409769 - Evaluation of the Tolerance of Ceftaroline and Ceftobiprole in the Management of BJI / PJI